rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BNR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Burning Rock Biotech Posts Q2 2026 Revenue Decline but Advances Fast-Track Reviews for Oncology NGS Kits

      Detailed price information for Burning Rock Biotech Ltd ADR (BNR-Q) from The Globe and Mail including charting and trades.

      Sep 11The Globe and MailBNR
      Burning Rock Reports Second Quarter 2026 Financial Results

      GUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2026. Recent Business Updates Therapy Selection & MRD OncoScreen® BCMatch Tissue Kit has officially entered the Priority Review Channel of the Center for Medical Device Evaluation (

      Sep 10Yahoo FinanceBNR

      This is the newest page. Registered accounts read further back.